AI Telephone

Emily Chen, a female born in 1995, has no known drug allergies. She has an active diagnosis of mild intermittent asthma since childhood. A recent pulmonary function test revealed an FEV1 at 92% of predicted. To manage her condition, she is currently prescribed an albuterol 0.09 mg/actuation inhaler (2 puffs as needed for shortness of breath) and montelukast 10 mg oral tablets (10mg daily).

Emily Chen is a 28-year-old female with a confirmed diagnosis of mild intermittent asthma, uncomplicated, with onset in childhood. The condition is currently active. She has no known allergies.

Pulmonary function testing shows an FEV1 of 92% predicted, which is interpreted as normal.

Her current medication regimen includes two active prescriptions for asthma management:

1. Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler – 2 puffs as needed for shortness of breath (dyspnea), typically 2–3 times per week, administered via oral (inhalation) route.
2. Montelukast 10 MG Oral Tablet – 10 mg once daily by mouth for maintenance therapy.

In summary, Ms. Chen has well-controlled mild intermittent asthma since childhood, supported by normal spirometry findings. She is maintained on daily montelukast with a rescue albuterol inhaler used on an as-needed basis. No known drug allergies are documented.

Emily Chen is a 28-year-old female (DOB: May 15, 1996) with a confirmed diagnosis of mild intermittent asthma, first identified at 5 years of age. Her most recent spirometry evaluation (May 1, 2024) demonstrated a normal FEV1/FVC ratio of 92%, indicating well-controlled airflow.

For asthma management, she is prescribed:

• Albuterol 90mcg inhaler – 2 puffs as needed for shortness of breath, with a maximum of 2 puffs per week.
• Montelukast 10mg oral tablet – 10mg daily for maintenance therapy.

She has no known drug allergies on record.

Emily Chen is a female patient born in 1998. Her active, confirmed problem list includes mild intermittent asthma (mild severity; ICD-10-CM J45.20, uncomplicated), with onset in childhood. For asthma management, she has an active medication order for albuterol 90 mcg/actuation inhaler, instructed as inhale 2 puffs by inhalation as needed for shortness of breath, typically used 2–3 times per week. She also has an active medication order for montelukast 10 mg oral tablet, instructed as take 10 mg by mouth once daily for maintenance. A final observation documented FEV1 percent predicted at 92%, interpreted as normal. Allergy documentation indicates an active, confirmed status of no known drug allergies.

Emily Chen, a 28-year-old female, has a history of mild intermittent asthma since childhood, which remains active. Her most recent pulmonary function testing demonstrated an FEV1 of 92% predicted, indicating well-preserved lung function.

For asthma management, she is prescribed:

• Albuterol 90mcg inhaler, with instructions to use 2 puffs as needed for shortness of breath, typically 2–3 times per week.
• Montelukast 10mg orally once daily for maintenance therapy.

She has no known drug allergies.

Emily Chen, a female born in 1998, has no known drug allergies. She has an active, confirmed diagnosis of mild intermittent asthma that has been present since childhood. A recent pulmonary function test revealed a normal FEV1 of 92% predicted. To manage her condition, she is currently prescribed a Montelukast 10 mg oral tablet to be taken daily for maintenance. Additionally, she has an active prescription for an Albuterol 90 mcg inhaler, with instructions to inhale 2 puffs as needed for shortness of breath, typically 2 to 3 times per week.

Emily Chen is a 28-year-old female (date of birth: May 15, 1996) with no known drug allergies. She has a confirmed, active diagnosis of mild intermittent asthma, with onset at age 5.

Her current medications include albuterol 90 mcg/actuation inhaler, 2 puffs as needed for shortness of breath, and montelukast 10 mg oral tablet taken once daily for maintenance therapy.

Pulmonary function testing performed on February 15, 2024, showed an FEV1 of 92% predicted, which was interpreted as normal.

Emily Chen is a female patient born in 1997. She has active, confirmed mild intermittent asthma (ICD-10 J45.20: mild intermittent asthma, uncomplicated), with onset in childhood. Her allergy record documents an active, confirmed status of no known drug allergies.

For asthma management, she has an active medication order for albuterol 0.09 mg/actuation metered dose inhaler, prescribed for her asthma, with instructions to use 2 puffs as needed for shortness of breath (dyspnea), typically 2 to 3 times per week. She also has an active medication order for montelukast 10 mg oral tablet for asthma maintenance, dosed at 10 mg once daily.

Pulmonary function testing has been completed with final results. A pulmonary function test panel was reported as final, including FEV1 percent predicted. Her FEV1 % predicted was 92%, interpreted as normal.